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Infectious Bursal Disease (IBD) is a highly contagious immunosuppressive disease of chickens 
caused by a Birnaviridae (IBDV). The ITA genotype was first detected in 2011 in Italy in IBD-
live vaccinated chickens. Full genome characterization confirmed ITA to be a genetically distinc-
tive IBDV. The aim of the study was to determine the pathogenicity of the ITA genotype in SPF 
chickens. Birds were housed in poultry isolators and inoculated at 35 days of life with ITA or 
STC IBDV strains. A control group was housed in analogous conditions and inoculated with ster-
ile water. All groups were daily observed for clinical signs up to 28 days post-inoculation (dpi). 
At 0, 7, 14, 21 and 28 dpi birds were bled for IBDV antibody detection by an ELISA Kit. At 2, 4, 
7, 14, 21 e 28 dpi 5 birds from each of the inoculated groups, and 3 from the control group, were 
euthanized and subjected to necropsy. Bursal and Thymus indexes were calculated; histological 
sections were examined and scored; viral tissue distribution determined by qRT-PCR in the bursa 
of Fabricious (BF), thymus, kidney, cecal tonsils, spleen, proventriculus, harder gland and bone 
marrow. No clinical signs, nor mortality were recorded in any group during the study. BF of both 
inoculated groups showed enlargement and oedema in the acute phase of the infection (2 dpi), 
followed by atrophy, which lasted until the end of the trial. Microscopic lesions of the BF of ITA 
IBDV inoculated birds consisted in lymphocyte depletion, cystic cavities and poor regeneration 
process. Viral RNA was persistently detected until the end of the trial in lymphoid tissues. The 
study showed that ITA genotype, though it has a subclinical course, causes a severe and persis-
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Infectious bursal disease (IBD) is a highly contagious immunosuppressive disease of 
chickens caused by infectious bursal disease virus (IBDV). IBDV belongs to the family Bir-
naviridae, genus Avibirnavirus, and has a bi-segmented dsRNA genome (Delmas et al., 2004). 
There are two recognized serotypes of IBDV, designated serotype 1 and 2; only serotype 1 
IBDVs have been known to cause naturally occurring disease in chickens. The primary target or-
gan of the virus is the Bursa of Fabricious (BF) where the virus infects and destroys dividing 
IgM–bearing B cells. IBDV includes different antigenic and pathogenic strains. Classical 
(cIBDV) isolates, firstly reported in USA in the 60’s (Cosgrove, 1962), cause, in receptive birds, 
acute disease characterized by ruffled feather, dehydration, watery diarrhea and prostration.  In-
fection of sensitive birds with classical strains can be also characterized by absence of clinical 
signs and mortality in the presence of bursal damage (Abdul et al., 2013; Sreedevi et al., 2007). 
In the early 1980s, antigenic variants (vaIBDV) of the virus were identified in the United States 
(Rosenberger and Cloud, 1985; Saif, 1984); vaccine strains available at that time did not elicit 
full protection against the variant, which were antigenically different from the classical isolates 
(Heine et al., 1991). vaIBDV isolates typically do not cause clinical signs but can cause discerni-
ble immunosuppression (Jayasundara et al., 2016; Sharma et al., 1989). In the mid-1990s, very 
virulent (vvIBDV) strains emerged in several European and Asian countries, causing >70% mor-
tality in sensitive chickens (Chettle et al., 1989; Eterradossi et al., 1992); these strains were 
shown to be mostly antigenically similar to the classical isolates (Abdel-Alim and Saif, 2001). 
The high mutation rate of IBDV RNA genome and the high selection pressure generated 
by application of intensive vaccination programs in birds can lead to the emergence of IBDV 
strains with new properties allowing them to persist in immune populations (Ingrao et al., 2013). 
Independently from the pathogenicity of the strain and the severity of clinical signs, 
IBDV infection is always associated with damage to the bursa of Fabricious and immunosup-
pression, often associated in field with impaired response to vaccinations and secondary infec-
tions (Sreedevi et al., 2007).  
 IBDV genotype ITA was first detected in 2011 in Italy in IBD-live vaccinated broilers 
(Lupini et al., 2016). Full genome characterization confirmed ITA to be a genetically distinctive 
IBDV genotype (Felice et al., 2017) and a recently proposed classification of IBDV into 




Arabia and Russia (Michel and Jackwood, 2017). At the present, genetics characteristics of 
IBDV have not been demonstrated to be factors in pathogenicity, and formal demonstration of 
the pathogenicity of an IBDV isolate requires it to be experimentally inoculated in susceptible 
chickens in comparison with a strain of known pathogenicity (Abdul et al., 2013). Currently 
available epidemiological and clinical data do not allow to define the pathogenicity of ITA geno-
type.  
To assess this point, an in vivo experimental study was conducted in specific pathogen-
free (SPF) chickens inoculated with ITA or a classical IBDV strain. Clinical signs, mortality, 
gross and microscopic lesions, bursal and thymus indexes, antibody response and IBDV loads on 








Infectious bursal disease virus (IBDV) belongs to Birnaviridae family, genus Avibirna-
virus (Delmas et al., 2004). Viruses of this family has genomes consisting in a bisegmented dou-
ble-stranded RNA (dsRNA) (Macdonald, 1980; Mueller et al., 1979). The Birnaviridae family is 
composed of 4 genera: Aquabirnavirus, dsRNA viral agents of fish, mollusks and crustaceans; 
Blosnavirus, whose type species is blotch snakehead virus (BSNV); Avibirnavirus, of which 
IBDV is the only species; and Entomobirnavirus, which includes viruses that infects insects 
(Delmas et al., 2004). 
 
b. Morphology 
The IBDV virion is non-enveloped, single-shelled, with an icosahedral symmetry capsid 
of about 70 nm in diameter, composed of 260 trimmers of VP2 that form spikes projecting radial-
ly from the capsid (Figure 1). The peptides derived from pre-VP2 C-terminal cleavages remain 
associated within the virion. VP3 forms a ribonucleoprotein complex with the genomic RNA. 











The genome is composed by two segments (Figure 2), A and B, of double-stranded RNA, 
coding for 5 viral proteins (VP): VP1, VP2, VP3, VP4 and VP5 (Eterradossi and Saif, 2013). 
Segment A is the larger one and consists of 3,254 base pairs (bp) that contains two open reading 
frames (ORF). The larger ORF encodes a polyprotein precursor (N-pVP2-VP4-VP3-C) that is 
self-processed from its protease in three viral premature proteins known as VP2, VP4 and VP3 
(Lejal et al., 2000). A small ORF partially overlaps the previous one and encodes the VP5 protein 
(Ganguly and Rastogi, 2018). Segment B consists of 2,817 bp that encodes for the polymerase 





Figure 2.  Organization of the IBDV genome. Segment A and Segment B and proteins encoded 
by them. ORF = open reading frames; VP = viral protein. Green: structural proteins; Rose: non-
structural protein VP5 and Blue: protease VP4 (SIB, 2018). 
 
ii. Viral proteins 
Five viral proteins are currently recognized in IBDV: VP1, VP2, VP3, VP4 and VP5 with 
approximate molecular weights of 97 KD, 41 KD, 32 KD, 28 KD, and 21 KD, respectively (Qin 
and Zheng, 2017). VP2, VP3, and VP1 are the structural proteins of IBDV. VP4 is a non-




VP1 is presumed to be the viral RNA-dependent RNA polymerase (RdRp), involved in 
replication and transcription of the virus, and exhibits an original organization as compared with 
other viral RdRps (von Einem et al., 2004). 
VP2 is the main capsid protein and it is, until now, the most important determinant for 
immunogenicity by eliciting the neutralizing antibody response of the host; it represents the mo-
lecular basis for antigenic variation (Vakharia et al., 1994). It forms trimmers which are the basic 
units of the virus shell (Coulibaly et al., 2005).  
VP3 is the internal capsid protein and the second major structural protein, it induces 
group-specific antibodies in the host, and interacts with all other components of the virus parti-
cles. It plays a critical role in virion morphogenesis, encapsidation, and replications (Chevalier et 
al., 2004; Garriga et al., 2007; Lombardo et al., 1999; Mertens et al., 2015; Tacken et al., 2000). 
VP4 is a viral protease that performs cleavages to control IBDV reproduction at several 
levels (Birghan et al., 2000). VP4 plays a major role in the maturation of capsid protein VP2, by 
progressively trimming several peptides at the VP2 carboxy-terminal extremity during virus as-
sembly (Lejal et al., 2000).  
 VP5 has no yet an established function but is predicted to be a structural analog of leucin 
rich repeat (LRR) family of proteins and to have functional implications arising from its structur-
al similarity to host Toll-like receptor (Tlr) 3; this function relates to the dual role of the protein 
in first abolishing and later inducing host cell apoptosis (Ganguly and Rastogi, 2018).  
 
c. Virus Replication 
The cellular viral cycle of IBDV consists of an adsorption phase followed by viral pene-
tration and replication in the cell cytoplasm (Yip et al., 2012). The first step of the infection oc-
curs by the binding of the virus to specific receptors present on the surface of the host cells. The 
virus was shown to be able to attach to chicken embryo kidney cells 75 minutes after inoculation 
(Lukert and Davis, 1974). The replication cycle in chicken embryo cells last 10-36 hours and the 
latent period is 4-6 hours (Becht, 1980; Jackwood and Saif, 1983; Lukert and Davis, 1974; Nick 
et al., 1976). In VERO and BGM-70 cells, a longer (48-hour) replication cycle was described 
(Jackwood and Saif, 1987; Kibenge et al., 1988; Lukert et al., 1975). The internalization of the 
bound IBDV particles occurs by a clathrin-independent endocytosis mechanism (Yip et al., 2012) 




The current proposed model for the assembly of IBDV particles involves most viral proteins, 
VP3 interacts with itself, pVP2 and VP1 with the viral genome, playing an important chaperone 
role in morphogenesis and in encapsidation (Tacken et al., 2000). The assembly process ends 
with the final maturation of pVP2 which cleavages the final peptide at the N-terminal level 
(Chevalier et al., 2004). Finally, the viral particles accumulate in the cytoplasm of the infected 
cells. This phenomenon is certainly promoted by the ability of VP5 to prevent apoptosis in the 
initial stages of infection by interfering with caspase and NF-KB (Liu and Vakharia, 2006). 
 
d. Susceptibility to physical and chemical agents and environment persistence 
IBDV is chemically and physically very stable virus and the main cause of its worldwide 
spread is its ability to persist in the environment, remaining infectious for 54-122 days after the 
removal of infected birds, cleaning and disinfection of sheds. IBDV is ultraviolet rays (UV) re-
sistant, withstands several physical and chemical agents as ether, chloroform and acidic pH (2.0), 
while it is rapidly inactivated at pH 12. Chloroderivatives and glutaraldehyde inactivate IBDV 
quicker than formol and iodine; the phenols and the quaternary ammonium salts are scarcely ef-
fective. Studies carried out by evaluating a high number of disinfectants have shown that a 2% 
chloramine solution, formalin at adequate temperature, glutaraldehyde and complex disinfectants 
containing formaldehyde, glutaraldehyde and alcohol dimethylbezolamino chlorohydrate can be 
used as efficient disinfectants (Eterradossi and Saif, 2013). 
e. Strain Classification 
IBDV strains are classified according to antigenicity, immunogenicity, molecular charac-
teristics and pathogenicity. 
 
i. Antigenicity 
Serotypes 1 and 2 of IBVD have been recognized and they share only 30% antigenic re-
latedness (McFerran et al., 1980). The 2 serotypes are differentiated by virus neutralizing (VN) 
tests, but not by fluorescent antibody tests or enzyme-linked immunosorbent assay (ELISA) and 
viruses pathogen for poultry belong to the serotype 1, while serotype 2 viruses are considered 
avirulent (Kibenge, 1988). Antigenic variant IBDV strains, which belongs to serotype 1, are anti-
genically different from classical IBDV strains (Ismail and Saif, 1991; Saif, 1984). Several ami-




the vaIBDV viruses (Heine et al., 1991; Lana et al., 1992; Vakharia et al., 1994). vvIBVD 
strains, first described in Europe (Chettle et al., 1989), are mostly antigenically similar to the 
cIBVD (Abdel-Alim and Saif, 2001; Eterradossi et al., 1992; Van Den Berg and Meulemans, 
1991; Van der Marel et al., 1990). 
 
ii.  Pathogenicity 
Virulent IBDV strains belong all to serotype 1, while serotype 2 strains include only avir-
ulent strains. The terms “classical”, “variant”, and “very virulent” have been used to define 
IBDV strains that exhibit differences in pathogenicity. Based on the signs and lesions observed in 
two lines of White Leghorn SPF chickens, during experimental IBD following  viral challenge, 
North American vaIBDV induced little if any clinical signs and no mortality but marked bursal 
lesions, cIBDV induced approximately 10–50% mortality and IBD typical signs and lesions, 
whereas vvIBDV induced approximately 50–100% mortality and typical IBDV signs and lesions 
(OIE, 2016). 
vaIBDV strains do not show certain VN epitopes that are typically present on classical 
strains. Therefore, they can break through high levels of maternal derived antibody elicited after 
cIBDV exposition and cause an early IBDV infection characterized by severe bursal atrophy and 
consequent immunosuppression (Sharma et al., 2000). 
 
iii. Genetic types and genogroups 
Genetic characterization of IBDV strain is generally based on the sequence of the VP2 
gene. 
A protocol of Reverse transcriptase- Polymerase chain reaction - Restriction enzyme 
fragment length polymorphisms (RT-PCR-RFLP) has been developed by Jackwood and Sommer 
(1997) and applied for classification of IBDV strains (Jackwood et al., 2001); six genetic types 
were identified. 
 This method of classification has been recently superseded by a new classification in 
genogroups proposed by Michel and Jackwood (2017) based on phylogenetic analysis of the hy-






In Table 2 classification in genogroups of reference IBDV strains is reported. Seven 
groups are currently recognized. cIBDV strains follow in genogroup 1, vaIBDV strains in-
genogroup 2 and vvIBDV strains in genogroup 3.  
ITA genotype cluster in genogroup n. 6 separately from other IBDV strains, having dis-
tinctive molecular characteristics as previously reported by Felice et al. (2017),  
 
Table 2. Classification of IBDV reference strains in genogroup (Michel and Jackwood, 2017). 
 
Genogroup Previous classification Reference strains (*accession number) 





2 Variant AL-2 (JF736011) 
DelE (AF133904) 
T1 (AF281238) 




4 dIBDV dIBDV/UY/2014/2202 (KT336459) 
MG4 (JN982252) 
TY2 (LC136880) 
5 Variant/classical recombinant Mexico04M101 (DQ916210) 
6 ITA genotype ITA-02 (JN852986) 






a. Geographical distribution  
IBD is reported worldwide, occurring in all major poultry producing areas of the world. 
Essentially, all flocks are exposed to the virus during the early stages of life, either by natural ex-
posure or vaccination. Due to vaccination programs carried out by most poultry producers, all 
chickens eventually become seropositive to IBDV (Sharma, 2000). vaIBDV strains seem to be 
predominant in the United States (Jackwood and Sommer-Wagner, 2005) but scattered outbreaks 
due to vvIBDV were recorded in California (Jackwood et al., 2009). In Canada recently vvIBDV 
were detected (Zachar et al., 2016). In Australia cIBDV viruses (Sapats and Ignjatovic, 2000) 
and a local type of vaIBDV (G7) have been reported (Jayasundara et al., 2016). 
In contrast, in Europe, vvIBDV seem to be the prevalent pathotype; the vvIBDV first de-
tections date back to the 90’s (Chettle et al., 1989; Eterradossi et al., 1992; Nunoya et al., 1992; 
Tsukamoto et al., 1992; Van Den Berg and Meulemans, 1991). However, de Wit et al. (2018) 
highlight the issue that surveys to attempt the detection of subclinical IBDV infections are quite 
uncommon in Europe. Therefore, this may lead to underdetection of IBDV strains that cause less 
or hardly any mortality but might cause serious immunosuppression such as the vaIBDV strains 
or other subclinical IBDV strains like the ITA genotype (Lupini et al., 2016; Felice et al., 2017) 
that could be emerging in Europe. Several reports suggest that they might be an underestimation 
of IBDV in Europe since mid-2000 (Jackwood and Sommer-Wagner, 2005; Letzel et al., 2007). 
In Brazil vvIBDV and vaIBDV seem to be circulating even in vaccinated flocks with live or re-
combinant vaccines (Muniz et al., 2018); while in other South American countries dIBDV strain, 
belonging to genogroup 4 has been frequently detected (Hernandez, 2016). 
vvIBDV are prevalent also in Africa (Abed et al., 2018; Mwenda et al., 2018; Sedeik et 
al., 2018). 
IBDV in Italy has been isolated for the first time in 1965, associated with classical forms 
of IBD accompanied by high mortality (Asdrubali and Franciosini, 1993). IBDV circulating 
strains in Italy belonged mainly to vvIBDV, followed by cIBDV and vaccinal strains (Moreno et 
al., 2010). A significant emergence of the genotype ITA has been reported (Lupini et al., 2016). 
Full genome characterization confirmed ITA to be a genetically distinctive IBDV genotype (Fe-
lice et al., 2017) recently classifies by Jackwood et al. (2017) into genogroups 6, together with 




b. Natural and experimental hosts 
Only chickens develop IBD after infection by serotype 1 viruses.  Turkeys may be 
asymptomatic carrier (Abdul et al., 2013). A serotype 1 virus was isolated from two 8-week-old 
ostrich chicks that had lymphocyte depletion in the bursa of Fabricius, spleen, and/or thymus 
(Eterradossi and Saif, 2013). Another serotype 1 isolate was obtained from healthy ducks 
(McFerran et al., 1980). Van den Berg et al. (2001) inoculated pheasants, partridges, and guinea 
fowl with a vvIBDV strain and did not report the occurrence of clinical signs or lesions referable 
to IBV in these species., Consistently Weisman and Hitchner (1978), were not able to produce 
disease in coturnix quail with a chicken-origin IBDV. Similarly, an earlier report showed that 
IBDV-inoculated Guinea fowl did not develop lesions or antibody (Okoye and Okpe, 1989). 
However, in quails the virus can replicate in BF and be shed for five days after infection (Van 
den Berg et al., 2001).  
Several species of free-living and captive birds of prey were examined by serology for 
antibodies to IBDV, and positive results were obtained from accipitrid birds (Ursula et al., 2001), 
from Rooks and wild pheasants (Campbell, 2001), from Antarctic penguins (Gardner et al., 
1997), from ducks, gulls and shearwaters (Wilcox and Flower, 1983) and from crows, gulls and 
falcons (Ogawa et al., 1998). 
 
c. Transmission 
IBDV is transmitted horizontally and no evidence suggests that IBDV is transmitted 
through eggs or that a true carrier state exists in recovered birds. The resistance of the virus to 
heat and disinfectants is enough to account for virus survival in the environment between out-
breaks (Eterradossi and Saif, 2013). Snedeker et al. (1967) demonstrated that lesser mealworm 
(Alphitobius diaperinus), taken from a poultry house 8 weeks after an outbreak of IBDV, was 
able to carrier IBDV to susceptible chickens when fed as a ground suspension. In another study 
performed by McAllister et al. (1995) found that the virus was isolated from several tissues of 
surface-sterilized lesser mealworm adults and larvae that were fed the virus earlier. 
 
d. Morbidity and mortality 
IBD appears suddenly, in fully susceptible flocks, showing a high morbidity rate, that can 




usually beginning on day 3 post-infection and peaking and receding in a period of 5–7 days 
(Eteradossi and Saif, 2013). Strains of vvIBDV can cause mortality rates up to 90% (Chettle et 
al., 1989) or 100% (Van Den Berg et al., 1991) in 4-week-old susceptible white leghorn chick-
ens. IBDV infections can be subclinical depending on the age of birds, in birds less than 3 weeks 
old, depending on the pathotype of the strain and on the presence of maternal antibody (Eter-




The most common way of IBDV infection is the oral route. Chickens are highly suscepti-
ble to IBDV infection from three to six weeks after hatching. Experiments in which bursecto-
mized chickens survived IBDV infection demonstrated that the bursa of Fabricious is the main 
target organ for the virus (Aricibasi et al., 2010). The acute phase of IBD usually lasts a week, 
and peak clinical signs and mortality are recorded 3- 4 days post-infection (Jackwood and Som-
mer-Wagner, 2011). After the entry via the gastrointestinal tract (GIT) IBDV is then transported 
to other tissues by phagocytic cells, thought to be resident macrophages (Aricibasi et al., 2010). 
IBDV has been shown to infect and destroy IgM bearing B cells in active mitosis within the BF 
(Rodenberg et al., 1994). In addition to targeting B cells, IBDV has been shown to be capable of 
infect and replicate in the macrophages. After infection IBDV has been reported to stimulate the 
production of pro-inflammatory mediators and cytokines, which peak during the early phase of 
viral replication (Aricibasi et al., 2010). Within the spleen cells, IBDV induces expression of IL-
1β, IL-6, IL-18 and inducible nitric oxide synthase (iNOS) (Aricibasi et al., 2010; Eldaghayes et 
al., 2006). T cells, although not actively infected by the virus have been suggested to modulate 
the pathogenesis of the infection by limiting the viral replication in the BF during the early phase 
of the infection, 5 days post-infection. This occurs via promoting tissue damage in the BF, via re-
leasing cytokines and cytotoxic effects, and delaying tissue recovery (Rautenschlein et al., 2002). 
Pathogenesis and immune responses of IBDV infection may vary depending on the age of the af-
fected chickens and the maturity of the bird’s immune system (Rautenschlein et al., 2007). IBDV 
infection of birds of more than 2 weeks induce T cell accumulation in the BF coinciding with the 
replication of the virus (Aricibasi et al., 2010). These intrabursal T cells are activated and play a 






Both clinical or subclinical IBDV infection cause immunosuppression in birds, compro-
mising humoral and cellular immune responses (Sharma et al., 2000). The destruction of imma-
ture B lymphocytes in the BF creates an immunosuppression, which will be more severe in 
younger birds (Faragher et al., 1974). In fact, the most severe and long-lasting immunosuppres-
sion occurs when day-old chicks are infected by IBDV. In field conditions, this rarely occurs 
since chickens tend to become infected at approximately two to three weeks, when maternal anti-
bodies decline. Evidence suggests that the immunosuppressive effect of the virus least up to six 
weeks of age (Van Den Berg et al., 2000). In commercial chicken flocks, immunosuppression 
may be clinically manifested in several ways. In general, the flock performance is reduced. Spe-
cifically, immunosuppressed flocks tend to experience an increased incidence of secondary infec-
tions, poor feed conversion, reduced protective response to commonly used vaccines, and an in-
creased rate of carcass condemnation at the processing plant (Sharma et al., 2000). 
IBDV causes a lytic infection of IgM+ B lymphocytes. Although B cell destruction is 
most pronounced in BF, evidence of viral replication and associated cellular destruction can also 
be found in several secondary lymphoid organs including cecal tonsils and spleen (Ivanyi & 
Morris, 1976; Okoye et al., 1990; Darteil et al., 1995). The cytolytic effect of IBDV on B cells 
leads to a dramatic reduction in circulating IgM+ B cells (Giambrone et al., 1977; Rodenberger et 
al., 1994). Only the primary antibody responses are impaired; the secondary responses remain in-
tact (Sharma et al., 2000). Although the data on the effect of IBDV on antigen-specific T cell 
functions are controversial, there is convincing evidence that in vitro mitogenic proliferation of T 
cells of IBDV-exposed birds is severely compromised. T cells in the spleen as well as in the pe-
ripheral circulation were affected (Confer et al., 1981; Kim et al., 1998). The mitogenic inhibi-
tion occurred early, during the first 3±5 days of virus exposure. Subsequently, the mitogenic re-
sponse of T cells returned to normal levels. IBDV modulates macrophage functions. There is in-
direct evidence that the in vitro phagocytic activity of these cells may be compromised (Lam, 
1998). 
A recent study conducted by Li, et al. (2018) demonstrates that IBDV infection leads to 
changes in the gut associated-lymphoid tissue (GALT) and the microbiota composition of chick-




acute phase of the disease what confirms previous studies showing IBDV infection may affect 
the number and morphology of mast cells (Wang et al., 2009). vvIBDV-infected birds had a low-
er abundance of Clostridium XIVa and an increase in the abundance of Faecalibacterium was 
observed in the acute phase of IBD. The trend was reversed after this phase. Therefore, it may 
suggest that vvIBDV interferes with the delicate balance of gut mucosal immunity and may sup-
port harmful intestinal inflammation.  
 
c. Clinical signs 
Severity of signs and lesions in infected birds depend on the virulence of the IBDV strain, 
race or genetic lineage, age and immune status, co-infection with other viruses, the dose and 
route of inoculation of the virus in experimentally infected birds. In studies based on the experi-
mental reproduction of acute IBD in SPF white leghorn chickens, vaIBDV induce little if any 
clinical signs and mortality but marked bursal lesion. cIBDV induced approximately 10–50% 
mortality with typical signs and lesions, and vvIBDV induced approximately 50–100% mortality 
with typical signs and lesions (Skeeles et al., 1979). 
The incubation period is short and clinical signs can appear in 2-3 days from virus expo-
sure (Helmboldt and Garner, 1964). Birds younger than 14 day-old do not appear susceptible to 
the disease if serologically positive to maternal immunity; birds of 3 to 6 week of age can 
demonstrate severe clinical signs (Mahgoub, 2012). 
In the acute clinical form Birds are depressed, with ruffled feathers and droopy appear-
ance, they may be seen pecking at their vent. Whitish or watery diarrhea and anorexia is also de-






Figure 3. Clinical signs of IBD: ruffled feathers, depression and watery diarrhea 
(https://albeitar.portalveterinaria.com/noticia/13000/articulos-aves/La-enfermedad-de-Gumboro-
I.html). 
Subclinical IBD occurs when chickens are exposed to IBDV during the first two weeks 
post hatch and have enough maternal antibody at time of infection to prevent clinical disease but 
not to prevent viral replication in the bursa. Immunosuppression and resultant increased suscepti-
bility to secondary infections are the major problem of subclinical IBD (Sharma, 2000). 
 
d. Gross lesions 
Birds that are affected by IBD, at post mortem examination are dehydrated, with dark 
discoloration of pectoral muscles. Pectoral, thigh and leg hemorrhages can be present (Figure 5) 
(Rinaldi et al., 1965). In advanced stages of the disease, kidneys can be pale due to severe urate 
diathesis caused by dehydration (Figure 6) (Cosgrove, 1962). Occasionally hemorrhages can be 






Figure 4. Petechial and ecchymosis on breast and thigh muscles (white arrows) in a chicken ex-
perimentally infected with vvIBDV (Raji et al., 2017). 
 
 
Figure 5. Chicken experimentally inoculated with the IBDV strain Bpop/03: spleen enlarged 










Figure 7. Hemorrhages at the juncture of the proventriculus and gizzard in chickens experimen-
tally inoculated with the IBDV strain Bpop/03 (Pikuła et al., 2018). 
 
The most severe macroscopic lesions are seen in bursa of Fabricious. In the early stages 
of the infection BF begins to increase in size because of edema and hyperemia. A gelatinous yel-
lowish transudate is covering the serosal surface of the organ (Figure 8). Longitudinal striations 
on the surface become prominent, and the normal white color turns to cream color. After 4-5 dpi, 




may become gray. From 8 dpi forward, it is approximately one-third its original weight, or even 
less (Cheville, 1967). The BF often shows necrotic foci and, at times petechial or ecchymotic 
hemorrhages on the mucosal surface. Occasionally, extensive hemorrhage throughout the entire 
bursa has been observed; in these cases, birds may void blood in their droppings (Eterradossi and 
Saif, 2013). 
 vvIBDV, however, cause similar lesions as cIBDV described above, although, bursal at-
rophy appears faster (Van Den Berg et al., 2000).  
vaIBDV were reported not to induce an inflammatory response (Rosenberger and Cloud, 
1985; Sharma et al., 1989), although 1 variant strain (IN) did so (Hassan, 1996) and cause a 
quicker and more severe bursal atrophy (Sharma et al., 1989).  
 
 
Figure 8. Chicken affected by IBD: bursa of Fabricious enlarged and oedematous. 
 
e. Histopathological lesions 
Microscopic lesions of IBD occur primarily in the lymphoid tissues like BF, spleen, thy-
mus, Harderian gland, and cecal tonsil and are notable more severe in BF (Eterradossi and Saif, 
2013). 
 
i. Bursal histopathological lesions 
Histopathological lesions due to cIBDV infection have been vastly described by Helm-




Degeneration and necrosis of lymphocytes in the medullary area of bursal follicles can be 
recognized in the early days post infection, Lymphocytes were soon replaced by heterophils, and 
hyperplastic reticuloendothelial cells. Hemorrhages often appear but are not consistently present. 
All lymphoid follicles can be affected by 3- 4 dpi (Figure 9) and severity depends of the patho-
genicity of the strain. The enlargement of the bursa seen at this time is caused by edema, hyper-
emia, and marked accumulation of heterophils. As the inflammatory reaction declines, cystic 








Figure 9. Differences in the severity of histopathologic lesions in sections of bursa of Fabricius 3 days post experimental inoculation 





ii. Thymus histopathological lesions 
In the early stages of infection thymus can exhibit cellular reaction in the lymphoid tis-
sues; classical strains are reported to cause more severe lesions in this organ than variant strains 
(Sharma et al., 1989; Tanimura and Sharma, 1998). Cortical atrophy (Figure 10) (Sharma et al., 




Figure 10. Histological sections of thymus of birds experimentally inoculated (5 dpi) with a 
vaIBDVstrain (A) or with a cIBDV strain (B). Corticomedullary junction is denoted by arrows 
cIBDV causes cortical atrophy (Sharma et al., 1989). 
 
4. Diagnosis 
a. Gross lesions 
When the virus reaches its main target organ (BF) it produces lesions and their extensions 
are compatible with its virulence and pathogenicity, viral load and the host’s immunity. In addi-
tion, other organs and tissues may present lesions, as demonstrated previously, due to these same 
factors. The evaluation of the appearance, consistency and size of the bursae are widely used to 
follow the dynamics of the disease. This is a useful tool for tracking the disease but should not be 
used as a single diagnostic method, since other diseases also cause considerable changes in BF 




Birds affected by IBD show injuries at BF as enlargement and turgid with a pale-yellow 
discoloration. Thigh and leg hemorrhages, enlargement of the liver and spleen and hemorrhages 
at the juncture of the proventriculus and gizzard can also be detected in the acute phase of the 
disease. In advanced stages of the disease, kidneys can be pale due to severe urate diathesis 
caused by dehydration (Eteradossi and Saif, 2013). Differences between acute and clinical forms 
are related with the severity and velocity of appearance of the of clinical signs and lesions (van 
Den Berg et al., 2000). Subclinical form commonly present only bursal atrophy (Sharma, 2000). 
b. Virus detection/isolation 
The viral antigen can be detected in smears BF or bursal sections by an immune-agar gel 
diffusion test (AGID), by immunofluorescence or immunostaining. 
Several antigen-capture enzyme-linked immunosorbent assays (AC-ELISA) have been 
developed for antigenic typing of IBDV strains. Virus isolation can be attempted by inoculation 
of the samples in SPF chicken embryonated eggs, or chicken embryo fibroblasts. Molecular tests 
are currently use in avian laboratories  
RT-PCR (Lin et al., 1994; Long Huw Lee et al., 1992; Vakharia et al., 1994) or real-time 
RT-PCR protocols (Moody et al., 2000; Peters et al., 2005) have been developed targeting the 
VP2 gene; some can differentiate classical, variant or very virulent strains of IBDV. 
c. Serology 
Serological tests as AGID, virus neutralization or ELISA are currently available to detect 
antibodies against IBDV in serum samples, but the most used routinely is the ELISA test. This 
test aim to measure titers of passive antibodies to determinate the date of vaccination in broiler 
flocks or in laying hens to verify proper vaccine intake (Sharma et al., 2000). 
 
5. Disease control 
The prophylaxis of Gumboro disease employs tools for the prevention and control of the 
occurrence or spread of this disease. It must necessarily be linked to its epidemiological chain 
that is applied to the sources of infection, transmission of the disease and susceptible birds. 
Measures of direct prophylaxis include cleaning and disinfection, with physical or chemical 
agents, of all fomites that get contact with the birds, as well as all the environment where they are 
housed. In addition, efforts should be made to avoid the contact of birds with possible dissemina-




Disinfectants such as formalin, chloramine and iodophor compounds have been shown to be ef-
fective against IBDV (Eteradossi & Saif, 2013). 
Control of IBD is achieved by vaccination. Live attenuated vaccines are commercially 
available and, according to the virulence of the strain, are classified in “mild”, “mild intermedi-
ate”, “intermediate”, “intermediate plus” or “hot”.  
However, effective control using conventional live vaccines requires proper timing of 
vaccination based on level of maternal antibody. While the live vaccines are susceptible to neu-
tralization by maternal antibodies, there is the potential for immunosuppression if birds are vac-
cinated when their antibody levels are too low (Rautenschlein et al., 2005). 
Inactivated vaccines are available and used in breeders at 16-20 weeks of age after the 
priming with an attenuated live IBDV vaccine at 8 weeks of age (Müller et al., 2012). These vac-
cines are used to produce a passive immunity in the progeny (Van Den Berg et al., 2000). 
Immune complex and recombinant vaccine administered safely and effectively at hatch-
ery have been recently developed and can be used in many countries. Immune complex vaccines 
are produced by mixing a well-defined proportion of attenuated IBDV, produced in embryonated 
eggs, with IBDV specific antibodies produced in SPF chickens inoculated with IBDV (Jeurissen 
et al., 1998). The recombinant vaccines use the Herpes virus of turkeys (HVT) as vector (Bublot 
et al., 2007) that is currently used to prevent Marek disease also with considerable efficacy 
(Gimeno et al., 2016). The VP2 gene from a donor IBDV is inserted into the genome of the HVT 
vaccine, which expresses the protein of IBDV as it replicates, thus inducing IBDV protection in 
vaccinated birds. Studies demonstrated high safety and efficacy of recombinant HVT-IBD vac-










Infectious bursal disease virus of ITA genotype (G6) reveals in SPF chickens 
 aggressiveness for lymphoid tissues despite a subclinical course 
 
Running title: in vivo pathogenicity study of an IBDV strain of ITA genotype (G6) 
Caterina Lupini1, Viviana Felice1, Flavio Silveira1, Giulia Mescolini1, Giacomo Berto
2, Valeria Listorti1, 
Mattia Cecchinato3, Elena Catelli1  
1Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell’Emilia (BO), Italy 
2CEVA Salute Animale, Agrate Brianza (MB), Italy 
3Department of Animal Medicine, Production and Health, University of Padua, Legnaro (PD), Italy  
 
Summary  
Recently, a new genotype of Infectious Bursal Disease Virus (IBDV), named ITA, was detected 
in IBD vaccinated Italian broilers. Genome characterization revealed ITA to be a genetically dif-
ferent IBDV placed into genogroup 6 of a recent IBDV classification. The currently available 
clinical data do not allow definition of the degree of pathogenicity ITA-IBDV genotype.  In the 
present study a pathogenicity trial has been conducted by inoculation of SPF chickens. Birds 
were housed in poultry isolators and inoculated at 35 days of life with a strain of the ITA IBDV 
genotype (35 birds) or a classical reference strain (35 birds).  Control birds (25 birds) were con-
textually mock inoculated with sterile water. Birds were daily observed for clinical signs and at 
0, 7, 14, 21- and 28-days post-inoculation (dpi) bled for IBDV antibody detection. At 2, 4, 7, 14, 
21 e 28 dpi, 5 birds from each of the inoculated groups, and 3 from the control group, were eu-




calculated. Microscopic lesions of bursa and thymus were scored on the basis of lymphoid necro-
sis and/or depletion or cortex atrophy, respectively. Both viruses induced a subclinical course of 
disease, as neither clinical signs nor mortality were recorded during the study, in presence of 
IBDV typical post-mortem lesions. Bursal damage, measured by the bursa-body weight ratio, 
was more noticeable, precocious and persistent after ITA-IBDV inoculation, significantly at 4 
and 28 dpi.  Histopathology of the bursa and thymus confirmed the higher aggressiveness for 
lymphoid tissues of the ITA-IBDV strain, indicating the scores a more severe lymphoid deple-
tion. The study showed that ITA genotype, though it has a subclinical course, causes a severe and 
persistent damage of lymphoid tissues. Therefore, its circulation in birds might be a threat for the 
poultry industry.  




Infectious bursal disease (IBD) is a highly contagious immunosuppressive disease of chickens 
caused by a bi-segmented dsRNA virus (IBDV), which belongs to the family Birnaviridae, genus 
an Avibirnavirus (Dalmas et al., 2019). There are two recognized serotypes of IBDV, designated 
serotypes I and II; only serotype I viruses have been known to cause naturally occurring disease 
in chickens. The primary target organ is the Bursa of Fabricius where the virus infects and de-
stroys dividing IgM–bearing B cells (Hirai and Calnek, 1979). IBDV of serotype I includes 
strains with different antigenicity and pathogenicity. Isolates known as “classical”, firstly report-
ed by Cosgrove (1962), can cause, in receptive birds, acute clinical disease characterized by ruf-




strains can be also characterized by absence of clinical signs and mortality, in the presence of 
bursal damage (Abdul et al., 2013; Sreedevi et al., 2007). In the early 1980s, antigenic “variants” 
of the virus were identified in USA (Rosemberg and Cloud, 1985; Saif, 1984) in respect of which 
vaccine strains available at that time were not able to elicit full protection (Heine et al., 1991).  
“Variant” isolates typically do not cause clinical signs of disease but always cause discernible 
immunosuppression (Jayasundara et al., 2017; Sharma et al., 1989). In the mid-1990s, “very viru-
lent" strains of IBDV appeared in European and Asian countries, these strains were shown to be 
mostly antigenically similar to the classical isolates (Abdel-Alim and Saif, 2001) and were able 
to cause outbreaks of disease characterized by an exacerbated acute phase and more than 70% 
mortality in sensitive chickens (Chettle et al, 1989; Eterradossi et al., 1992);  
Independent of the pathogenicity of the strain and the severity of clinical signs, IBDV infection is 
always associated with damage to the bursa of Fabricius and immunosuppression, often fol-
lowed, in the field, by infections with other pathogens and impaired immune response to other 
vaccinations (Sreedevi et al., 2007). 
The high mutation rate of IBDV genome can lead to the emergence of strains with new antigenic 
and pathogenic properties, which can persist and circulate in immunized commercial chickens 
(Ingrao et al., 2013).  
In 2011, a new genotype of IBDV, named ITA, was detected in IBD-live vaccinated Italian 
broilers (Lupini et al., 2016). Full genome characterization confirmed ITA to be a genetically dif-
ferent IBDV (Felice et al., 2017) and a recently proposed classification for IBDV into 
genogroups, placed ITA genotype into genogroup 6, together with few other strains detected in 
Saudi Arabia and Russia (Michel and Jackwood, 2017).  The currently available epidemiological 




ogenicity since the viruses have been detected in IBDV vaccinated broilers, sometimes with poor 
performances, hence provided with some kind of immune protection which could have masked 
the clinical course of the disease.  
The ITA-IBDV genotype shows peculiar molecular characteristics, as it has most of the muta-
tions that affect charged or potentially glycosylated amino acids in key positions of the hypervar-
iable region of the VP2 protein. These mutations may be virtually associated with major changes 
in virus properties, with VP2 being the primary antigenic and virulence determinant of IBDV 
(Nagarajan and Kibenge,1997).  
The aim of this study was to determine the virulence of IBDV of ITA genotype. A pathogenicity 
study has been conducted by inoculation of Specific-pathogen-free (SPF) chickens in secure iso-
lation conditions with an IBDV strain recognized to belong to the ITA genotype and observation 
of clinical signs, macro/microscopic lesions, antibody response and damage of bursa of Fabricius 
and thymus.  
 
MATERIAL AND METHODS 
Ethics statement 
Experimental trial was performed in agreement with national regulations on animal experiments 
and animal welfare (UE Directive 2010/63/EU), according to authorization N°635/2015-PR pro-
vided by the Italian Ministry of Health. 
Chickens 
Ninety-five SPF chickens were used. Birds were housed in secure isolation facilities for the dura-






Two field isolates of IBDV were used in the study, named, according with the new nomenclature 
proposed by Jackwood et al. (2018), IBDV 1/chicken/Italy/1829/11/(G6) (ITA genotype, 
genogroup 6) and IBDV 1/chicken/Italy/24II/12/(G1a) (STC genotype, genogroup 1). The virus 
of the STC genotype was used as reference control in the pathogenicity test as suggested by OIE 
(2016).     
Virus isolation was obtained from bursal homogenates that tested positive for IBDV ITA or STC 
genotypes by RT-PCR and sequencing (Jackwood et al., 2008). Inocula were prepared as a 20% 
(weight/volume) suspension of positive bursae in Minimal Essential Medium (MEM) containing 
antibiotics and antimycotics (penicillin, streptomycin and amphotericin B) (Applied Biosystems, 
CA, USA). The supernatant (0.2 ml/egg) was used to inoculate ten 12-day-old specific pathogen 
free (SPF) chicken embryonated eggs via the chorioallantoic membrane (CAM) route (Senne, 
2008).  The eggs were incubated at 37.7°C until embryo death was recorded or up to 7 days post-
inoculation. From the eggs suspected to be infected, due to embryo death or presence of embryo 
lesions, the CAMs were aseptically harvested, homogenized, pooled and prepared as 20% (w/v) 
suspensions. IBDV isolation was confirmed by RT-PCR (Jackwood et al., 2008). Viruses were 
afterwards titrated in SPF eggs (Villegas, 2008) and titers were calculated by the method of Reed 
and Muench (1938). Viral stocks were examined by PCR assays for avian adenovirus (Raue and 
Hess,1998) and chicken anemia virus (Imai et al.,1998), to exclude contamination.  
 
Experimental design 
Birds were tagged and divided into three groups, housed in separate isolators, and named as fol-




days of age ITA-IBDV and STC-IBDV groups were orally inoculated with a dose of 104.5 
EID50/per bird of IBDV1/chicken/Italy/1829/11/(G6) or IBDV1/chicken/Italy/24II/12/(G1a) vi-
ruses, respectively. Chickens of the control group were kept as negative control and mock inocu-
lated with sterile water. After inoculation birds were monitored and scored daily for clinical signs 
as previously reported (Le Neuen et al., 2012).  
Before inoculation, and at 7, 14, 21- and 28-days post-infection (dpi), ten birds per group were 
bled and sera were tested for circulating anti-IBDV antibody by ELISA assay. At 2, 4, 7, 14, 21 
and 28 dpi, five birds from ITA-IBDV group, five from STC-IBDV group and three from the 
control group were euthanatized, weighted and post-mortem examined for macroscopic lesions.  
Bursae and thymuses were collected, weighted for the subsequent calculation of the bursa-body 
weight (B:BW) or thymus-body weight (T:BW) ratios, and fixed in 10% neutral buffered forma-
lin for histological score of lesions. The experiment was terminated at 28 dpi. 
 
Serology 
Anti-IBDV antibody titers were determined using the commercial Infectious Bursal Disease Vi-
rus Antibody test kit (BioCheck, Reeuwijk, The Netherlands) following the manufacture’s in-
structions. Sera samples with an antibody titer >391 were considered positive. 
Geometric mean of ELISA antibody titers were compared through t-student test, for differences 
among groups. A p-value <0.05 was considered statistically significant. 
 
Bursa-body weight and thymus-body weight ratios 
Body weight and bursa or thymus weights were used to calculate the bursa-body (B:BW) or thy-




B:BW or T:BW ratio = [organ weight (g)/body weight (g)]×1000 
The means of the B:BW or T:BW ratios per group, at each day-point sampling, were compared 
through Wilcoxon-Mann-Whitney non-parametric test for differences among groups. A p-value 
<0.05 was considered statistically significant. 
 
Histological Scores of bursa and thymus lesions 
Fixed tissues were dehydrated in grades alcohols, cleared with xylene, embedded in paraffin 
wax, sectioned, and stained with haematoxylin and eosin.  
Bursa lesions were scored from 0 to 4, on the basis of lymphoid necrosis and/or depletion accord-
ing to Sharma et al. (1989) as follows: 0=less than 5% of the lymphoid follicles affected; 1= 5-
25% of lymphoid follicles affected; 2= 25-50% of lymphoid follicles affected; 3=50-75% of 
lymphoid follicles affected and 4= more than 75% of lymphoid follicles affected.   
Thymus lesions were evaluated on the bases of cortex atrophy and expressed as percentage of 
cortex area/lobule area.  Photomicrographs of two thymic lobules from each thymus sample were 
acquired with a digital camera connected to an optical microscope; digital image analysis was 
performed using ImageJ software (Schneider et al., 2012).  Thymic medulla and lobule images 
were manually delineated in order to calculate their areas. Scores were expressed as percent of 
cortex area/lobule area.  
Mean histological scores were compared through t-student test, for differences among groups. A 








Clinical signs and gross lesions 
Neither clinical signs, nor mortality were observed during the study in all experimental groups.  
At post-mortem examination, from 2 dpi, bursae of Fabricius of birds of both virus-inoculated 
groups were enlarged, and a gelatinous yellowish transudate was covering the serosal surface. 
Atrophy of the bursae takes over from 4 dpi in birds of the ITA-IBDV group (Figure 1) and from 
7 dpi in birds of STC-IBDV group. The atrophy lasted until the end of the trial and, at 28 dpi was 
more severe in birds of the IBDV ITA group (Figure 2).  In both inoculated groups, from 2 to 7 
dpi, hemorrhages in the thigh muscles (Figure 3) and/or a slight enlargement of spleen, showing 
grey foci uniformly dispersed on the surface, were observed. No post-mortem lesions were ob-
served in the control birds at any time. 
Bursa-body weight and thymus-body weight ratios 
Bursa-body weight and thymus-body weight ratios means are reported in table 1. At 4 dpi, the 
mean of the B:BW ratios of the ITA-IBDV group was significantly lower than the means of the 
B:BW ratios of the STC-IBDV group and of the control group (p values<0.05), confirming what 
was observed at the post-mortem examination. At 7, 14 and 21 dpi, the means of the B:BW ratios 
of both virus-inoculated groups were significantly lower than the mean of the B:BW ratios of the 
control group (p value<0.05) but did not differ each other (p values>0.05). At 28 dpi the mean of 
the B:BW ratios of the ITA-IBDV group was significantly lower that the one of the STC-IBDV 
group (p values<0.05). 
At 4 dpi the mean of T:BW ratios of the STC-IBDV group was significantly lower (p<0.005) 




mean of the T:BW ratios of the controls (p<0.005). Both virus-inoculated groups, at the end of 
the trial, showed a higher mean of the T:BW ratios than the control group (p<0.005) (Table 1).  
Serology  
No ELISA anti-IBDV antibodies were detected in the control group at any time during the trial 
and in the ITA-IBDV and STC-IBDV groups before inoculation. From 7dpi, anti-IBDV antibody 
have been detected, and titers have increased up to the end of the trial in both inoculated birds. At 
7 dpi, birds of ITA-IBDV group showed a significantly higher mean antibody titer (9650 ± 1300) 
than the birds of the STC-IBDV group (7329 ± 1285), while were not statistically different in the 
following days of sampling (Figure 4). 
Bursa and thymic histologic lesion scores 
Mean histologic lesion scores of bursa and thymus are reported in table 2. Extensive microscopic 
lesions were observed in the bursa of virus-exposed birds from 2 dpi, which persisted through the 
observation period of 28 days (Figure 5, 6 and 7). A statistically significant difference between 
mean of bursa scores of virus-inoculated groups was recorded at 2dpi (p<0.05), scoring higher 
the ITA-IBDV group. At the following sampling days, the means of bursa scores of both virus-
inoculated groups were significantly higher than the mean of the control group (p value<0.05) 
but did not differ each other (p values>0.05). 
Thymus cortical atrophy was observed in birds of virus-inoculated groups from 2dpi up to the 
end of the trail (Figure 8). A statistically significant difference between mean of thymus scores of 
virus-inoculated groups was recorded at 2dpi (p<0.05), scoring lower the ITA-IBDV group. At 
the subsequent sampling days, the means of thymus scores of virus-inoculated groups were sig-







In the present study a pathogenicity trial has been conducted by inoculation of 5 weeks-old SPF 
chickens with an IBDV strain recognized to belong to the ITA genotype, in order to assess its 
virulence in comparison to a “classical” STC strains. Both viruses induced a subclinical course of 
disease, as neither clinical signs nor mortality were recorded during the study, in presence of 
IBDV typical post-mortem lesions. Bursal damage, measured by the bursa-body weight ratio, 
was more noticeable, precocious and persistent after ITA IBDV inoculation, significantly at 4 
and 28 dpi. This feature has been previously described for “variant” IBDV, which have been re-
ported to cause earlier and more severe bursal atrophy than “classical” strains (Hussan et al., 
1996, Sharma et al., 1989; Jayasundara et al., 2017). Histopathology scores of the bursa and thy-
mus confirmed the higher aggressiveness for lymphoid tissues of the ITA-IBDV strain, indicat-
ing the scores a more severe lymphoid depletion, as previously reported by Sharma et al., (1989) 
for American “variant” strain.  
It is universally recognized that IBDV-induced damage of the bursa of Fabricius is related to 
immunosuppression; moreover, IBDV strains that have been shown to involve other lymphoid 
organs, such as thymus, can cause even more severe immune disorders (Sharma et al., 1989, 
1992). A damage in thymus lymphoid tissues is reported to be indicative of a highly aggressive 
nature of the examined IBDV strain (Timura and Sharma, 1998; Rauf et al., 2013), and may rep-
resent a generalized inflammatory response to a acute virus infection (Sharma et al., 1989). In the 
present study at microscopic level, a significant reduction of the thymus cortex was observed in 
the ITA-IBDV inoculated birds, not associated to atrophy of the organ as previously described 




A significantly earlier antibody response was detected in ITA-IBDV group, when compared to 
STC-IBDV group. This characteristic was previously addressed as high virulence indicator, in 
the acute phase of IBDV infection, for an Australian variant strain (Jayasundara et al., 2017). The 
authors also observed that the early antibody response was correlated to a faster virus clearance 
from host tissues; this point need to be further investigated for the IBDV of the ITA genotype by 
performing a dynamic virus distribution in vivo study. It is known that during IBDV infection, 
the immune response against the virus itself is not affected; this seems to be a paradox as there is 
immunosuppression in respect of other antigens. Different mechanisms could be involved that se-
lectively stimulate the proliferation of the B cells committed to anti-IBDV antibody production 
(Withers et al., 2005; Jakka et al., 2014).   
The molecular markers of virulence of IBDV have not yet firmly established, therefore the as-
sessment of the pathogenicity of a new viral genotype of epidemiological relevance, trough ex-
perimental infection of sensitive birds remains an essential point.  It has been suggested that 
more than one molecular determinant, either located in segment A or B of the genome, contribute 
to the virulence of IBDV (Nagarajan & Kibenge, 1997).  Complete sequence analysis of a strain 
of the ITA IBDV genotype revealed the coexistence in the aminoacidic sequence of some resi-
dues, including virulence markers, in common with very virulent strains, and others typical of 
IBDV strains at low degree of virulence (Felice et al., 2017).  
Our present study shows that a strain belonging to the ITA genotype, inoculated in SPF chickens, 
is able, though it has a subclinical course, to cause a severe and persistent damage of bursal tis-
sues and, in addition, to involve the thymus. For its unique molecular characteristics ITA geno-
type was shown to cluster phylogenetically apart from classical, variant and very virulent IBDV 




lates, into Genogroup 6. Michel and Jackwood (2017) report that Saudi Arabia strains were de-
tected in flocks with suspected non-very virulent IBDV infection; this could suggest that these 
strains have a similar subclinical course as experimentally demonstrated in the present study for 
an IBDV of the ITA genotype. Moreover, the protection offered by common vaccination sched-
ules to ITA IBDV is still unknown and need to be further investigated by in vivo cross-protection 
studies using existing IBDV vaccines.   
Strains of ITA genotype are still circulating in Italy (Lupini et al., 2018) often under detected 
during routine diagnostic activity; and due the absence of overt clinical signs and mortality can 
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Table 1. Mean Bursa: BW and thymus:BW ratios (± standard deviations) of experimental groups 
by day post-inoculation (dpi). Different superscripts indicate that the difference between groups 
is statistically significant (p<0.05). 
 Mean Bursa:BW ratio  Mean Thymus:BW ratio 
dpi STC-IBDV ITA-IBDV Control  STC-IBDV ITA-IBDV Control 
2 6.1* (±2.33) 6.3* (±1.44) 4,8* (±1.27)  10.7* (±1.07) 10.0* (±2.96) 9.6* (±0.80) 
4 4.7* (±1.11) 2.3** (±0.29) 4.2* (±0.18)  5.0* (±1.17) 7.0** (±0.87) 9,8*** (±0.63) 
7 1.0* (±0.35) 1.3* (±0.14) 4.3** (±1.02)  7.4* (±1.16) 6.3* (±0.35) 7.6* (±1.27) 
14 0.7* (±0.50) 0.3* (±0.15) 4.1** (±1.58)  10.0* (±2.86) 7.4* (±1.69) 9.8* (±4.92) 
21 1.0* (±0.38) 0.7* (±0.43) 3.0** (±0.42)  10.0* (±2.00) 9.3* (±2.02) 8.1* (±1.85) 










Table 2. Mean histological lesion scores of bursa and thymus of experimental groups by day post-
inoculation (dpi). Different superscripts indicate that the difference between groups is statistical-
ly significant (p<0.05). 
 Bursa lesion score  Thymus lesion score 
dpi STC-IBDV ITA-IBDV Control  STC-IBDV ITA-IBDV Control 
2 2.2* 4** 0***  65,2* 58,9** 71,2*** 
4 3.6* 4* 0**  46,4* 49,5* 65,1** 
7 3.6* 4* 0**  65,7* 62,2* 72,9** 
14 4* 4* 0**  64,6* 67,9* 65,7** 
21 4* 4* 0**  65,1* 67,2* 66,9** 









Figure 1. Post mortem lesions in SPF chickens at 4 dpi: (A) control group (B) ITA-IBDV group and (C) 
STC-IBDV group. A gelatinous yellowish transudate is covering the serosal surface of bursae of birds of 
both virus-inoculated groups. Furthermore, atrophy of the bursa begins to be present in the ITA-IBDV 
group. 
  





Figure 2. Bursae of Fabricius of SPF chickens at 28 dpi: (A) control group (B) ITA-IBDV group and (C) 
STC-IBDV group.  The bursae of viruses-inoculated birds showed atrophy, which appeared more severe 






Figure 3. Hemorrhages in the thigh muscle of a SPF chicken inoculated with the IBDV strain of the ITA 







Figure 4. Mean IBDV antibody titres in ITA-IBDV and STC-IBDV groups by days post-













Figure 5. Histopathology of bursa of Fabricius of SPF chickens at 2dpi (X40 magnification): (A) 
Figure 5. Normal lymphoid follicles in control birds; (B) severe follicular lymphocytes depletion 
in birds of ITA-IBDV group; (C) mild follicular lymphocytes depletion in birds of STC-IBDV 
group.  
  











Figure 6. Histopathology of bursa of Fabricius of SPF chickens at 14 dpi (X40 magnification): 
(A) Normal bursal plicae in control birds; fold atrophy and follicular lymphocytes depletion in 













Figure 7. Histopathology of bursa of Fabricius of SPF chickens at 28 dpi (X40 magnification): 
(A) Normal pattern of bursa in control birds; fold atrophy, cistic degeneration and early lymphoid 
repopulation in bursae of birds of the ITA-IBDV (B) and STC-IBDV (C) groups.  
 
  









Figure 8. Histopathology of thymus of SPF chickens at 2 dpi (X40 magnification): (A) virus-free 
control; cortical atrophy in ITA-IBDV (B) and STC-IBDV (C) groups. 
 
  





Comparative dynamic tissue distribution and shedding of infectious bursal disease virus 
(IBDV) of ITA (G6) or classical (G1) genotypes by qRT-PCR after experimental infection 
of SPF chickens 
 
 
Aim of the study 
The present study was aimed to evaluate by quantitative reverse transcription PCR (qRT-PCR), 
the tissue distribution, persistence and fecal shedding of IBDV following experimental infection 
of specific pathogen free (SPF) chickens with a strain recognized to belong to the ITA genotype 
(G6) or a classical (G1) reference strain. 
 
Material and methods 
 
Ethical statements 
Experimental trial was performed in agreement with national regulations on animal experiments 
and animal welfare, according to authorization N°635/2015-PR by the Italian Ministry of Health. 
 
Chickens 
Seventy-eight SPF chickens were used. Birds were housed in secure isolation facilities for the 
duration of the study and food and water were given ad libitum.  
 
Viruses 
Two field isolates of IBDV were used in the study, named, according with the new nomenclature 
proposed by Jackwood et al. (2018), strain IBDV 1/Italy/1829/11/(G6) (ITA genotype, 
genogroup 6) and strain IBDV 1/Italy/23II/12/(G1) (STC genotype, genogroup 1).  
Viruses were isolated and inocula were prepared and titrated as described in chapter 2.  
 
Experimental design 
Birds were tagged and divided into three groups named as follows: ITA-IBDV group (30 birds), 




IBDV and STC-IBDV groups were orally inoculated with 104.5 ELD50 of ITA or STC viruses, re-
spectively. Chickens of the control group were kept as negative control and mock inoculated with 
sterile PBS. The groups were housed in separate isolators and the experiment was terminated 28 
days post infection (dpi).  
At 2, 4, 7, 14, 21 and 28 dpi, samples were collected for virus detection and quantification by 
qRT-PCR.  From five birds of ITA-IBDV group, five from STC-IBDV group and three from the 
control group, cloacal swabs were collected.  Birds were subsequently euthanized and from each 
of them tissue samples from bursa of Fabricius (BF), spleen, thymus, bone marrow, cecal tonsils 
and harderian gland, kidney, liver and proventriculus were collected.  
 
Cloacal swabs processing 
After sampling, the cloacal swabs were let to air dry under laminar flow cabinet. Once dried, the 
swabs were kept at room temperature until processing.  
For elution each swab was dip in 250 µl of PBS in a 2 mL tube and vortexed for 1 min. After-
wards, the tubes were centrifuged at 4,500 rpm for 5 minutes at +4 °C. The swab was then re-
moved from the tube and the eluted was stored at -80°C until RNA extraction. 
 
Tissue collection and processing 
Tissues were collected aseptically using separate sterile scissors and forceps and stored at -80 °C 
until processing. Tissue samples were weighed in a sterile 2 mL tube, and, to obtain a 10% sus-
pension weight/volume (w/v), sterile PBS was added in accordance with the following formula: 
 
                   PBS (ml) = weight of the organ or tissue (g) x 9 
 
After homogenization for 10 seconds, samples were centrifuged at 2,000 rpm for 15 minutes at + 
4 °C, the supernatant was collected and placed into a new 2 ml tube for storage in at -80 °C until 
viral RNA extraction.  
 
RNA extraction and qRT-PCR for IBDV 
The viral RNA extraction from eluted samples was carried out using Solution D containing 




qRT- PCRs were developed and validated for this study to specifically detect and quantify ge-
nomes of IBDV of ITA or STC genotypes. Primers and probes were designed (Table 1) on the 
variable regions of VP2. The assay was performed using SuperScript® III Platinum® One-Step 
qRT-PCR Kit (InvitrogenTM, Carlsbad, CA, USA) on LightCycler® Nano Instrument (Roche, 
Basel, Switzerland) following the manufacturer’s instructions. The reaction profile used was: 50 
°C for 15 min for RT step, 95 °C for 2 min, and 45 cycles of 95 °C for 15 sec, and 60 °C for 30 
sec for the PCR step. The assay was validated using titrated virus suspensions (5.4 Log10 
EID50/mL for the STC genotype strain, 5.2 Log10 EID
50/mL for the ITA genotype strain), ac-
counting for the qRT-PCR detecting both viable and non-viable viral particles in tissues or swab 
samples. The qRT-PCR limit of detection (LoD50) was evaluated using serial 10-fold RNA dilu-
tions in negative matrices, performed in quadruplicate, ranging from the undiluted virus to a final 
10-7 dilution. LoD50 was defined as the lowest viral amount detectable in at least 50% of the rep-
licates. LoD50 was 10
0.49EID50/mL for the STC strain and 100.49EID50/mL for the ITA strain. 
Standard curves generated for each titrated IBDV genotype strain were obtained and used for 
quantification by fitting a linear regression relating Cp and Viral titer. Additionally, the curves 
allowed to evaluate reaction efficiency and coefficient of determination, which were proven to be 
92%-103% and higher than 0.97, respectively. All samples were tested in duplicates.  
 
Statistical analysis 
Data were analyzed using Fisher exact test and significant statistical differences between groups 
were reported when p<0,05. The viral genome quantity means were transformed to Log10, and 
then the non-parametric Wilcoxon test was performed (SPSS, IBM) to assay statistical differ-
ences in RNA loads between groups, with 95% confidence interval. 
 
Results 
Results of IBDV detection in samples collected from birds of ITA-IBDV or STC-IBDV group, 








Detection and quantification of ITA-IBDV and STC-IBDV genomes in lymphoid tissues 
 
Bursa of Fabricius 
No statistically significant differences between virus-inoculated groups were found in the number 
of bursa IBDV positive birds per days of sampling  (Table 2). Quantification of viral RNA in 
bursal tissues showed that, at 4 and 7 dpi, the mean of RNA load in ITA-IBDV group was signif-
icantly higher (p<0.05) than the RNA load in STC-IBDV group (Figure 1).  
 
Spleen 
At 2 dpi spleens of virus-inoculated birds were all positive for IBDV (Table 2), although the 
quantification showed that ITA-IBDV group had a higher RNA load (p<0.05) compared to STC-
IBDV group (Figure 2). At 14 dpi, higher number of positive birds and higher viral load (p<0.05) 
were also observed in ITA-IBDV group compared to STC-IBDV group. At 28 dpi, STC-IBDV 
group showed higher number of positive birds (p<0,05) compared to ITA-IBDV group (Table 2), 
but the viral load was not statistically different between groups (Figure 2).  
 
Thymus 
A significant higher number of IBDV positive birds (p<0.05) were observed in ITA-IBDV group 
at 14 dpi compared to STC-IBDV group. Furthermore, at 2, 4, 7 and 14 dpi ITA-IBDV group had 
a significant higher RNA load (p<0.05) compared to STC-IBDV group (Figure 2). 
 
Bone marrow 
IBDV RNA was more frequently detected in ITA-IBDV group than in STC group in bone mar-
row, as is deductible by total number of detections and RNA quantification at 2, 4, 7, 14 and 28 
dpi (p<0.05) (Figure 2). 
 
Cecal tonsils 
No statistically significant differences between IBDV-inoculated groups were found in the num-
ber of cecal tonsil positive samples per day of sampling. Quantification of viral RNA showed 
that, at 4, 14, 21 and 28 dpi, ITA-IBDV group had a higher mean RNA load in cecal tonsils 






Only at 2 dpi, ITA-IBDV group showed a higher RNA load (p<0.05) compared to STC-IBDV 
group (Figure 2). 
 




A statistically higher number of positive birds (p<0.05) were observed at 14 dpi in ITA-IBDV 
group compared to STC-IBDV group. Furthermore, at 2, 4, 7 and 14 dpi kidneys of ITA-IBDV 
group had a higher RNA load (p<0.05) compared to kidneys of STC-IBDV group (Figure 3). 
 
Liver 
Only at 4 dpi, ITA-IBDV group showed a statistically higher RNA load in liver (p<0.05) com-
pared to STC-IBDV group (Figure 3). 
 
Proventriculus 
At 2, 4 and 28 dpi STC-IBDV group shower higher number of birds IBDV positive in proven-
triculus (p<0,05) compared to ITA-IBDV group (p<0.05). The viral load was not different be-
tween IBDV-inoculated groups (p>0.05) (Figure 3). 
 
Viral shedding 
A higher number of positive swabs were found at 4 dpi, in birds of STC-IBDV group (p<0,05) 
compared to the birds of ITA-IBDV group (p<0.05) (table 2); however the viral load was not sta-











This study showed that a strain of the ITA genotype could be detected in SPF birds experimental-
ly infected, for up to 28 dpi in lymphoid or non-lymphoid tissues, with higher load in bursa of 
Fabricius, cecal tonsils and bone marrow. As expected, the bursa of Fabricius has been confirmed 
to be the most important site for IBDV replication. Both viruses were detected in bursa until 28 
dpi and at notable load. Seen the higher viral load detected, most lymphoid organs are likely to 
play an important role in viral persistence in chickens. 
Moreover, in the present study is confirmed, for both tested viruses, that non-lymphoid tissues, 
play a marginal role in IBDV persistence, as previously reported by Abdul et al. (2013) for a var-
iant and a classical IBDV strains.  In particular within non-lymphoid organs, viral load is negli-
gible in proventriculus.  
Significant higher viral loads (p <0.05) were found in ITA strain- inoculated birds, in all organs 
tested except for proventriculus. Most part of those differences is found in the first two-week 
post-infection, especially in bursa, thymus, bone marrow and kidney. Moreover, bone marrow 
presented the same tendency until the endpoint of the experiment. Cecal tonsils of ITA-IBDV in-
oculated birds showed a notable viral load, higher than the one detected in the bursa, at the end 
point of the trial.   
For this reason, cecal tonsils and bone marrow may serve as non-bursal lymphoid tissues sup-
porting virus replication at later time points post-infection. Nevertheless, the detection of vRNA 
is not indicative of the presence of the infectious virus, and virus isolation has to be performed to 
prove the presence of infectious particles.  
IBDV fecal shedding is known to be short lasting after infection (Takase et al., 1982; Zhao et al., 
2013), this is confirmed by our results for both tested viruses, although the shedding of the ITA 
IBDV strain is even shorter, being the virus excreted only for the first 48 hours post-infection. 
The faster antibody response observed in ITA IBDV strain inoculated birds (see chapter 2) can 
be one reason explaining this behaviour.  A similar hypothesis was previously advanced to ex-
plain a faster clearance for lymphoid organs of birds experimentally infected with Australian or 
US variants (Abdul et al., 2013; Jayasundara et al., 2017). 
The dynamic distribution and persistence of an IBDV strains of the ITA genotype after experi-




tion rate of the tested virus in lymphoid tissues. This can be taken as support to the notion that 
this new genotype possesses a high aggressiveness, as demonstrated in the pathogenicity study 





Table 1. Primers and probes designed and used for detection and quantification by qRT-PCR,  
of STC and ITA genotypes of IBDV in tissues and swabs. 
 
Primer Classical Position in the genome 
STC-IBDV    
Forward TGGAGACTATGGGCATCTAC 2715-2734a 
Reverse CGGTATTTCTCGTGTGTTCT 2805-2824a 
Probe TAGCACTCAATGGGCACCGA 2754-2773a 
   
ITA-IBDV    
Forward CTCAGCCTGCCCACATCATA 389-408b 
Reverse CGTTACCCCACCTTGTTGGT 549-568b 
Probe AGGCTTGGWGACCCCATTCC 425-444b 
a Based on the sequence of IBDV, strain 150127/0.2 (GenBank accession no.: MF969107). 






Table 2. IBDV RNA detection in lymphoid and non-lymphoid tissues, and in swabs. 
 
Sample 
2 dpia  4 dpi  7 dpi  14 dpi  21 dpi  28 dpi Total 
STC ITA  STC ITA  STC ITA  STC ITA  STC ITA  STC ITA STC ITA 
                    
Lymphoid tissues                    
Bursa 5  5   5 5  5 5  4 5  4 5  4 4 27 29 
Spleen 5  5  5 3  5 5  1* 4*  2 3  5* 1* 23 21 
Thymus 4 5  5 5  4 5  1*  5*  0 0  2 2 16 22 
Bone marrow 4 4  5 5  3 5  3 5  0 3  0* 5* 15* 27* 
Cecal tonsils 5 4  5 5  5 3  2 4  4 5  3 5 24 26 
Harderian gland 3 3  5 3  1 2  2 3  0 1  2 3 13 15 
                    
Non-lymphoid tissues                    
Kidney 5 2  4 4  4 5  0* 5*  0 1  1 0 15 17 
Liver 5 5  5 4  3 3  3 1  0 0  0 0 16 13 
Proventriculus 4* 0*  5* 1*  1 1  1 0  0 1  4* 0* 15* 3* 
                    
Shedding                    
Swabs 5 4  4* 0*  3 1  0 0  0 0  0 1 12 6 
a Day post-inoculation. 
b Number of birds out of 5 from which viral RNA was detected. 





Figure 1. IBDV RNA load in bursa of Fabricius of birds of virus-inoculated experimental 









Figure 2. IBDV RNA load in lymphoid tissues of birds of virus-inoculated experimental groups. 











Figure 3. IBDV RNA load in non-lymphoid tissues of birds of virus-inoculated experimental 






Figure 4. Mean RNA shedding in ITA-IBDV or STC-IBDV inoculated groups. The different let-







The pathogenicity characterization of a strain of a distinctive genotype of IBDV as ITA 
genotype is extremely important to understand how IBDV has evolved in order to circumvent the 
control strategies that have been developed over time. The in-depth pathological study of these 
new strains is fundamental to improve strategies to control and prevent IBD. 
Recently, the emergence of distinctive strains of IBDV has occurred worldwide and 
strains causing subclinical form of IBDV have been shown to be a big challenge to poultry 
health, since they can lead to infections with secondary pathological agents, such as Escherichia 
coli, through immunosuppression and a decreased response to vaccines for other important poul-
try pathogens. 
In the present thesis a strain belonging to the IBDV ITA genotype, strain IBDV 
1/Italy/1829/11/(G6) was, for the first time, inoculated in SPF chickens to determine virulence 
and tissue distribution in comparison to an IBDV strain belonging to the classical STC genotype.  
Results showed that ITA genotype is able, thought it as a subclinical course, to cause a 
severe a persistent damage of bursal tissues and, in addition to involve the thymus. Moreover vi-
ral load in lymphoid tissues of ITA-inoculated birds resulted to be significantly higher than in 
birds inoculated with the classical strain. Taken together these results indicate aggressiveness of 
the new genotype for the lymphoid tissues, which may be indicative of a significant immunosup-
pressive potential.  
Protection conferred by the existing commercial vaccines to ITA IBDV genotype infec-
tion is still unknown and need to be further investigated trough in vivo cross-protection studies in 
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